Thu Jan 6, 2022 – 6:39 pm ESTThu Jan 6, 2022 – 7:54 pm EST
WASHINGTON, D.C. (LifeSiteNews) – In a pair of post-Christmas tweets, U.S. Rep. Thomas Massie of Kentucky highlighted one of the key reasons for ongoing distrust of the new COVID-19 vaccines: federal rules shielding drug companies from consequences for the downsides of their products under certain conditions.
According to the Congressional Research Service (CRS), the federal Public Readiness and Emergency Preparedness (PREP) Act of 2005 “authorizes the Secretary of Health and Human Services (HHS) to limit legal liability for losses relating to the administration of medical countermeasures such as diagnostics, treatments, and vaccines.” Near the beginning of the 2020 COVID-19 outbreak, HHS invoked the Act in declaring the virus a “public health emergency.”
Under this “sweeping” immunity, CRS explains, the federal government, state governments, “manufacturers and distributors of covered countermeasures,” and licensed or otherwise-authorized health professionals distributing those countermeasures are shielded from “all claims of loss” stemming from those countermeasures, with the exception of “death or serious physical injury” brought about through “willful misconduct,” a standard that, among other hurdles, requires the offender to have acted “intentionally to achieve a wrongful purpose.”
The remainder of this article is available in its entirety at LifeSite News
The views expressed in this news alert by the author do not directly represent that of The Official Street Preachers or its editors